Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 17 October 2025 to Question 77387 on Hormone Replacement Therapy, what steps he is taking to support women receiving treatment with Testo-100 HRT implants following (a) the recent recall of current stock by the distributor and (b) the current lack of alternative supplies of HRT implants.

The Department continues to work closely with the Medicines and Healthcare products Regulatory Agency (MHRA) and can confirm that we have engaged with specialist importers to understand if they can source this product, but unfortunately, they have not been able to. We have also approached a supplier which has a product that is licensed in the United States but are yet to receive a response.

In the longer term, the MHRA is working with the importer Smartway, in an expedited fashion, to encourage full United Kingdom Marketing Authorisations for these products in 2026, which if successful, should bring about a safer and more stable supply.